Team:ULB-Brussels/Safety
From 2014.igem.org
(Difference between revisions)
Line 22: | Line 22: | ||
The containment of the bacteria should not be a primary issue: </p> | The containment of the bacteria should not be a primary issue: </p> | ||
- | + | Indeed, our project has a build-in biocontainment component. The antitoxin production is under </p> | |
- | + | the control of an arabinose-dependant promoter. If the bacteria escape from the bioreactor, they will no longer </p> | |
- | + | be provided with arabinose, thus they will stop producing the antitoxin and they will quickly die. </p> | |
-</section> | -</section> |
Revision as of 11:45, 1 August 2014
$~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ \newcommand{\MyColi}{{\small Mighty\hspace{0.12cm}Coli}} \newcommand{\Stabi}{\small Stabi}$ $\newcommand{\EColi}{\small E.coli} \newcommand{\SCere}{\small S.cerevisae}\\[0cm] ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ \newcommand{\PI}{\small PI}$ $\newcommand{\Igo}{\Large\mathcal{I}} \newcommand{\Tgo}{\Large\mathcal{T}} \newcommand{\Ogo}{\Large\mathcal{O}} ~$
|
---|